+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025

  • ID: 4866606
  • Report
  • December 2019
  • Region: Global
  • 228 Pages
  • Markets and Markets
1 of 6
The Global NGS Market is Projected to Grow at a CAGR of 20.9% During the Forecast Period

FEATURED COMPANIES

  • 10x Genomics
  • Eurofins Scientific
  • Genotypic Technology
  • Illumina, Inc.
  • Macrogen.
  • Qiagen N.V.
  • MORE

The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period
The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. The NGS market is segmented based on application, technology, product & service, end user, and region.

The SBS segment accounted for the largest share of the NGS market in 2018
On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of SBS-based NGS platforms (including the HiSeq MiSeq series and NextSeq).

The diagnostics application segment accounted for the largest share of the NGS market in 2018
Based on applications, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications, which include marine research and research in biofuels, forensics, metagenomic studies, and evolutionary studies. Of all these application segments, diagnostics accounted for the largest share of the NGS market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

North America accounted for the largest share of the NGS market in 2018
North America accounted for the largest share of the NGS market in 2018, followed by Europe. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

Some of the prominent players in the NGS market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), Hamilton Company (US), Lucigen (US), Intrexon Bioinformatics GmbH (Germany), Partek Incorporated (US), DNASTAR, Inc. (US), DNAnexus (US), SciGenom Labs Pvt. Ltd. (India), GENEWIZ (US), Takara Bio Inc. (Japan), Eurofins Scientific (Luxembourg), 10x Genomics (US), F. Hoffmann- La Roche Ltd (Switzerland), Becton Dickinson and Company (US), Danaher (US), Lexogen GmbH (Austria), Tecan Trading AG (Switzerland), Zymo Research (US), Oxford Nanopore Technologies (UK), Agilent Technologies, Inc. (US), and QIAGEN (Netherlands).

Research Coverage
This report studies the NGS market based on product & service, technology, application, end user, and region. It studies major factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four major regions and their respective major countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the NGS market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 10x Genomics
  • Eurofins Scientific
  • Genotypic Technology
  • Illumina, Inc.
  • Macrogen.
  • Qiagen N.V.
  • MORE

1 Introduction  
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology  
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Size Estimation
2.3 Market Breakdown & Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary  

4 Premium Insights  
4.1 Next-Generation Sequencing Market Overview
4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025
4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)
4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)
4.6 Next-Generation Sequencing Market: Geographical Snapshot

5 Market Overview  
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in NGS Platforms
5.2.1.1.1 Iseq
5.2.1.1.2 Ion Genestudio S5
5.2.1.2 Declining Costs
5.2.1.3 Improving Regulatory & Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints
5.2.2.1 End-User Budget Constraints in Developing Nations
5.2.3 Opportunities
5.2.3.1 Government & Private Support for Large-Scale Sequencing
5.2.3.2 Application of NGS in Precision Medicine & Molecular Diagnostics
5.2.3.3 NGS Data Analysis Using Big Data
5.2.4 Challenges
5.2.4.1 Interpretation of Complex Data From NGS Platforms
5.2.4.2 Ethical Issues
5.2.5 Industry Trends
5.2.5.1 Development of Portable Sequencing Technology
5.2.5.2 Partnerships and Collaborations for Technological Advancements in NGS

6 Next-Generation Sequencing Market, By Product & Service  
6.1 Introduction
6.2 Presequencing Products & Services/Sample Preparation
6.2.1 Sample Preparation is the First Step of an NGS Workflow
6.2.1.1 Library Preparation & Target Enrichment
6.3 NGS Consumables
6.3.1 Growing Number of Sequencing Procedures to Propel the Demand for NGS Consumables
6.4 NGS Platforms
6.4.1 Illumina
6.4.1.1 Increasing Installations of Sequencers to Propel Market Growth
6.4.1.2 Hiseq Systems
6.4.1.3 Hiseq X Ten & Hiseq X Five
6.4.1.4 Miseq Systems
6.4.1.5 Nextseq Systems
6.4.1.6 Miniseq Systems
6.4.1.7 Novaseq Systems
6.4.1.8 Iseq 100 Systems
6.4.2 Pacific Biosciences
6.4.2.1 Pacific Biosciences Systems are Restricted to Smaller Genomes and Applications Where Long Reads are Required
6.4.2.2 Pacbio Rs Ii
6.4.2.3 Sequel Systems
6.4.3 Thermo Fisher Scientific
6.4.3.1 Ion PGM Systems Contributed to the Largest Share of the Company’s Revenue in the NGS Platforms Market
6.4.3.2 Ion PGM Systems
6.4.3.3 Ion Proton
6.4.3.4 Ion Genestudio S5
6.4.4 Oxford Nanopore Technologies
6.4.4.1 Sequencers Offered By Oxford Nanopore Technologies are Expected to Witness Significant Adoption in the Coming Years
6.4.5 Other NGS Platforms
6.5 Services for NGS Platforms
6.5.1 Increasing Installation of NGS Platforms to Support Market Growth
6.6 Sequencing Services
6.6.1 Exome & Targeted Resequencing and Custom Panels
6.6.1.1 Development of Technologically Advanced NGS Products and Services to Propel Market Growth
6.6.2 Rna-Seq
6.6.2.1 Launch of Advanced Rna Products and Services to Drive Market Growth
6.6.3 Whole-Genome Sequencing & De Novo Sequencing
6.6.3.1 Reducing Whole-Genome Sequencing Costs to Propel the Growth of This Segment
6.6.4 Other Sequencing Services
6.7 Bioinformatics
6.7.1 NGS Data Analysis Software & Workbenches
6.7.2 NGS Data Analysis Services
6.7.2.1 Availability of Data Analysis Services is the Major Factor Supporting the Growth of This Market.
6.7.3 NGS Storage, Management, and Cloud Computing Solutions
6.7.3.1 Launch of Cloud-Based Solutions to Drive the Market

7 Next-Generation Sequencing Market, By Technology  
7.1 Introduction
7.2 Sequencing By Synthesis
7.2.1 SBS Technology Enables the Highest Production of Base Pairs in A Short Period of Time
7.3 Ion Semiconductor Sequencing
7.3.1 Ion Semiconductor Sequencing Platforms Possess High-Throughput Capabilities
7.4 Single-Molecule Real-Time Sequencing
7.4.1 SMRT Sequencing Produces Results in A Short Time and at Lower Costs
7.5 Nanopore Sequencing
7.5.1 Nanopore Sequencing is the Only Sequencing Technology With Direct Rna-Sequencing Capabilities
7.6 Other Sequencing Technologies

8 Next-Generation Sequencing Market, By Application  
8.1 Introduction
8.2 Diagnostics
8.2.1 Cancer Diagnostics
8.2.1.1 Growing Number of New Cancer Cases to Propel Market Growth
8.2.2 Infectious Disease Diagnostics
8.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases to Hamper Market Growth
8.2.3 Reproductive Health Diagnostics
8.2.3.1 Increasing Awareness About the Benefits of NIPT to Propel Market Growth
8.2.4 Other Diagnostic Applications
8.3 Drug Discovery
8.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery to Support Market Growth
8.4 Agricultural & Animal Research
8.4.1 Growing Funding & Support for Animal & Plant Genomics Research to Drive Market Growth
8.5 Other Applications

9 Next-Generation Sequencing Market, By End User  
9.1 Academic Institutes & Research Centers
9.1.1 Development of Cost-Effective NGS Products and Services for Researchers to Propel Market Growth
9.2 Hospitals & Clinics
9.2.1 Development of Advanced NGS-Based Diagnostic Solutions to Enhance the Adoption of NGS in Hospitals and Clinics
9.3 Pharmaceutical & Biotechnology Companies
9.3.1 Growing Agreements and Collaborations Between NGS Market Players and Pharma Biotech Firms to Fuel Market Growth
9.4 Other End Users

10 Next-Generation Sequencing Market, By Region  
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing R&D Activities in the US to Drive Market Growth
10.2.2 Canada
10.2.2.1 Increasing Government Initiatives in Genomics Research Will Boost the Adoption of NGS Technology
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Dominates the European NGS Market
10.3.2 France
10.3.2.1 Government Initiatives to Support Genomics Research - Major Factor Driving Market Growth in France
10.3.3 UK
10.3.3.1 Favorable Funding Scenario for Genomics Research in the Country to Support the Adoption of NGS
10.3.4 Spain
10.3.4.1 Increasing Number of Conferences Focusing on NGS to Support Market Growth in Spain
10.3.5 Italy
10.3.5.1 Favorable Funding Scenario to Drive the NGS Market in Italy
10.3.6 Netherlands
10.3.6.1 Increasing Focus of Market Players on Developing NGS Technologies to Support Market Growth
10.3.7 RoE
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China to Register the Highest Growth in the APAC NGS Market
10.4.2 Japan
10.4.2.1 High Incidence of Genetic Disorders in the Country has Resulted in the Increased Adoption of NGS
10.4.3 Australia
10.4.3.1 Increasing Public and Private Initiatives to Support the Adoption of NGS Technologies in Australia
10.4.4 India
10.4.4.1 Growing Prevalence of Target Diseases in India to Support Market Growth
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 High Prevalence of Hiv in Brazil to Drive the Demand for NGS
10.5.2 Mexico
10.5.2.1 Economic Growth in Mexico to Support the Growth of the NGS Market
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Lack of Infrastructure for Genomics Research to Hamper the Growth of the NGS Market in the MEA

11 Competitive Landscape  
11.1 Introduction
11.2 Competitive Leadership Mapping
11.2.1 Terminology/Nomenclature
11.2.1.1 Visionary Leaders
11.2.1.2 Innovators
11.2.1.3 Dynamic Differentiators
11.2.1.4 Emerging Companies
11.3 Competitive Scenario (2015-2019)
11.4 NGS Market Ranking, By Top Three Market Players (2018)

12 Company Profiles  
12.1 Agilent Technologies, Inc.
12.2 Illumina, Inc.
12.3 Qiagen N.V.
12.4 F. Hoffmann-La Roche AG
12.5 Thermo Fisher Scientific, Inc.
12.6 Genewiz (A Part of Brooks Automation)
12.7 BGI Group
12.8 Perkinelmer
12.9 Eurofins Scientific
12.10 Macrogen.
12.11 Oxford Nanopore Technologies
12.12 10x Genomics
12.13 Takara Bio
12.14 Zymo Research
12.15 Nugen Technologies (Part of Tecan Trading AG)
12.16 Hamilton Company
12.17 Beckman Coulter (A Subsidiary of Danaher)
12.18 Becton, Dickinson and Company
12.19 Genotypic Technology
12.20 Lucigen Corporation

13 Appendix  
13.1 Discussion Guide
13.2 Knowledge Store
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (121 Tables)

Table 1 Partnerships & Collaborations, 2017–2019
Table 2 Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 3 Presequencing Products & Services Market, By Region, 2017–2025 (USD Million)
Table 4 Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 5 Library Preparation & Target Enrichment Market, By Region, 2017–2025 (USD Million)
Table 6 Quality Control Market, By Region, 2017–2025 (USD Million)
Table 7 NGS Consumables Market, By Region, 2017–2025 (USD Million)
Table 8 NGS Platforms Market, By Type, 2017–2025 (USD Million)
Table 9 NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 10 Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 11 Illumina NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 12 Hiseq Systems Market, By Region, 2017–2025 (USD Million)
Table 13 Hiseq X Ten & Hiseq X Five Market, By Region, 2017–2025 (USD Million)
Table 14 Miseq Systems Market, By Region, 2017–2025 (USD Million)
Table 15 Nextseq Systems Market, By Region, 2017–2025 (USD Million)
Table 16 Miniseq Systems Market, By Region, 2017–2025 (USD Million)
Table 17 Novaseq Systems Market, By Region, 2017–2025 (USD Million)
Table 18 Iseq 100 Systems Market, By Region, 2017–2025 (USD Million)
Table 19 Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 20 Pacific Biosciences NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 21 Pacbio Rs Ii Systems Market, By Region, 2017–2025 (USD Million)
Table 22 Sequel Systems Market, By Region, 2017–2025 (USD Million)
Table 23 Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 24 Thermo Fisher Scientific NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 25 Ion PGM Platforms Market, By Region, 2017–2025 (USD Million)
Table 26 Ion Proton Systems Market, By Region, 2017–2025 (USD Million)
Table 27 Ion Genestudio S5 Platforms Market, By Region, 2017–2025 (USD Million)
Table 28 Oxford Nanopore Technologies NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 29 Other NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 30 Services for NGS Platforms Market, By Region, 2017–2025 (USD Million)
Table 31 NGS Sequencing Services Market, By Type, 2017–2025 (USD Million)
Table 32 NGS Sequencing Services Market, By Region, 2017–2025 (USD Million)
Table 33 NGS Bioinformatics Market, By Product & Service, 2017–2025 (USD Million)
Table 34 NGS Bioinformatics Market, By Region, 2017–2025 (USD Million)
Table 35 Next-Generation Sequencing Technologies, By Company
Table 36 Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 37 Sequencing By Synthesis Market, By Region, 2017–2025 (USD Million)
Table 38 Ion Semiconductor Sequencing Market, By Region, 2017–2025 (USD Million)
Table 39 Single-Molecule Real-Time Sequencing Market, By Region, 2017–2025 (USD Million)
Table 40 Nanopore Sequencing Market, By Region, 2017–2025 (USD Million)
Table 41 Other Sequencing Technologies, By Region, 2017–2025 (USD Million)
Table 42 Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 43 Next-Generation Sequencing Market for Diagnostics, By Type, 2017–2025 (USD Million)
Table 44 Next-Generation Sequencing Market for Diagnostics, By Region, 2017–2025 (USD Million)
Table 45 Next-Generation Sequencing Market for Agricultural & Animal Research, By Region, 2016–2024 (USD Million)
Table 46 Next-Generation Sequencing Market for Other Applications, By Region, 2016–2024 (USD Million)
Table 47 Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 48 Next-Generation Sequencing Market for Academic Institutes & Research Centers, By Region, 2017–2025 (USD Million)
Table 49 Next-Generation Sequencing Market for Hospitals & Clinics, By Region, 2017–2025 (USD Million)
Table 50 Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, By Region, 2017–2025 (USD Million)
Table 51 Next-Generation Sequencing Market for Other End Users, By Region, 2017–2025 (USD Million)
Table 52 Next-Generation Sequencing Market, By Region, 2017–2025 (USD Million)
Table 53 North America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 54 North America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 55 North America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 56 North America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 57 North America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 58 North America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 59 North America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 60 North America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 61 North America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 62 North America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 63 US: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 64 Canada: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 65 Europe: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 66 Europe: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 67 Europe: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 68 Europe: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 69 Europe: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 70 Europe: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 71 Europe: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 72 Europe: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 73 Europe: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 74 Europe: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 75 Germany: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 76 France: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 77 UK: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 78 Spain: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 79 Italy: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 80 Netherlands: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 81 RoE: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 82 Asia Pacific: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 83 Asia Pacific: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 84 Asia Pacific: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 85 Asia Pacific: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 86 Asia Pacific: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 87 Asia Pacific: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 88 Asia Pacific: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 89 Asia Pacific: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 90 Asia Pacific: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 91 Asia Pacific: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 92 China: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 93 Japan: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 94 Australia: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 95 India: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 96 RoAPAC: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 97 Latin America: Next-Generation Sequencing Market, By Country, 2017–2025 (USD Million)
Table 98 Latin America: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 99 Latin America: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 100 Latin America: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 101 Latin America: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 102 Latin America: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 103 Latin America: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 104 Latin America: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 105 Latin America: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 106 Latin America: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 107 Brazil: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 108 Mexico: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 109 RoLA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 110 MEA: Next-Generation Sequencing Market, By Product & Service, 2017–2025 (USD Million)
Table 111 MEA: Presequencing Products & Services Market, By Type, 2017–2025 (USD Million)
Table 112 MEA: Next-Generation Sequencing Platforms Market, By Type, 2017–2025 (USD Million)
Table 113 MEA: Illumina Platforms Market, By Type, 2017–2025 (USD Million)
Table 114 MEA: Thermo Fisher Scientific Platforms Market, By Type, 2017–2025 (USD Million)
Table 115 MEA: Pacific Biosciences Platforms Market, By Type, 2017–2025 (USD Million)
Table 116 MEA: Next-Generation Sequencing Market, By Technology, 2017–2025 (USD Million)
Table 117 MEA: Next-Generation Sequencing Market, By Application, 2017–2025 (USD Million)
Table 118 MEA: Next-Generation Sequencing Market, By End User, 2017–2025 (USD Million)
Table 119 New Product Launches
Table 120 Acquisitions
Table 121 Partnerships, Agreements, and Collaborations

List of Figures (39 Figures)

Figure 1 Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 NGS Market: Product-Based Estimation
Figure 5 NGS Platforms Market: Product-Based Estimation
Figure 6 NGS Market: Application-Based Estimation
Figure 7 NGS Market: Data Triangulation
Figure 8 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)
Figure 9 Next-Generation Sequencing Market, By Technology, 2019 vs 2025 (USD Million)
Figure 10 Next-Generation Sequencing Market Share, By Application, 2019 vs 2025
Figure 11 Next-Generation Sequencing Market Share, By End User, 2019 vs 2025
Figure 12 Next-Generation Sequencing Market: Geographical Snapshot
Figure 13 Increasing Applications of NGS in Diagnostics and Genomics Research to Drive Market Growth
Figure 14 NGS Consumables to Dominate the NGS Market During the Forecast Period
Figure 15 Sequencing By Synthesis to Hold the Largest Share of the Market During the Forecast Period
Figure 16 Diagnostic Applications to Hold the Largest Share of the NGS Market in 2019
Figure 17 Academic Institutes & Research Centers to Hold the Largest Share of the NGS Market in 2019
Figure 18 China is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 19 NGS Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Cost of Human Whole-Genome Sequencing, 2001–2019
Figure 21 Data Production During Human Whole-Genome Sequencing, 2001–2019
Figure 22 Funding for Cancer Research in the US (2018)
Figure 23 Number of Pubmed Research Publications on NGS-Based Drug Discovery, 2008–2017
Figure 24 North America: Next-Generation Sequencing Market Snapshot
Figure 25 Asia Pacific: Next-Generation Sequencing Market Snapshot
Figure 26 NGS Market, Competitive Leadership Mapping, 2018 (Overall Market)
Figure 27 NGS Market, Competitive Leadership Mapping, 2018 (Sme/Start-Ups)
Figure 28 Key Developments in the NGS Market, 2016–2019
Figure 29 Illumina Held the Leading Position in the NGS Market as of 2018
Figure 30 Illumina Held the Leading Position in the NGS Platform Market as of 2018
Figure 31 Agilent Technologies: Company Snapshot (2018)
Figure 32 Illumina: Company Snapshot (2018)
Figure 33 Qiagen N.V. : Company Snapshot (2018)
Figure 34 Roche: Company Snapshot (2018)
Figure 35 Thermo Fisher Scientific: Company Snapshot (2018)
Figure 36 Brooks Automation, Inc.: Company Snapshot (2018)
Figure 37 Perkin Elmer: Company Snapshot (2018)
Figure 38 Takara Bio: Company Snapshot (2018)
Figure 39 Tecan: Company Snapshot (2018)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Genewiz (A Part of Brooks Automation)
  • BGI Group
  • Perkinelmer
  • Eurofins Scientific
  • Macrogen.
  • Oxford Nanopore Technologies
  • 10x Genomics
  • Takara Bio
  • Zymo Research
  • Nugen Technologies (Part of Tecan Trading AG)
  • Hamilton Company
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Genotypic Technology
  • Lucigen Corporation
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll